13 December 2021 | News
The company aims to double the number of its active cath labs in India
Image credit: businesswire
Royal Philips has announced the completion of 1000 active Cath lab (interventional suite) installations in India. Over the last quarter, the company has installed its state-of-the-art Azurion cath labs at major sites across the country including Fortis, Apollo, Aster, Manipal, NH and Jayadeva Institute of Cardiovascular Sciences and Research Hospitals.
The completion of 1000 active cath lab installations mark a major milestone in Philips’ mission to create innovative solutions designed to meet the company’s Quadruple Aim of better health outcomes, improved patient experience, improved staff experience, and lower cost of care.
Over the next few years, Philips aims to double the number of its active cath labs in India with a special focus on improving the accessibility to quality cardiac and neurovascular care in tier II and tier III cities.
Philips is continuously innovating to bring in solutions such as the first spectral detector angio-CT solution that combines breakthrough spectral detector CT imaging and real-time fluoroscopy in a flexible environment where all modalities are operated through Philips Image-Guided Therapy System – Azurion with FlexArm. Philips’ Spectral detector CT imaging in the interventional suite will bring valuable additional information in minimally invasive procedures for areas such as oncology, stroke, and trauma care.